Metraipolis › archive › dc_f778c5bf8d32
In silico investigation of thiazole-semicarbazide hybrids as dual GSK-3β/Tau inhibitors for Alzheimer's disease — Europe PMC PMID:42236499
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42236499
- DOI
- 10.1038/s41598-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T20:36:55.902Z
- SHA-256 of the archived text
6b8d65229f404bf26ea6537ef618fa2214451d2fd936c87bd80dc394cb1a27e1- Stable URL of this page
https://metraipolis.com/documento/dc_f778c5bf8d32
How to cite
In silico investigation of thiazole-semicarbazide hybrids as dual GSK-3β/Tau inhibitors for Alzheimer's disease — Europe PMC PMID:42236499 — Europe PMC (en), https://europepmc.org/article/MED/42236499 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f778c5bf8d32 (Metraipolis archive dc_f778c5bf8d32, sha256 6b8d65229f404bf26ea6537ef618fa2214451d2fd936c87bd80dc394cb1a27e1)
BibTeX
@misc{dcf778c5bf8d32,
title = {In silico investigation of thiazole-semicarbazide hybrids as dual GSK-3β/Tau inhibitors for Alzheimer's disease — Europe PMC PMID:42236499},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42236499},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f778c5bf8d32; sha256 6b8d65229f404bf26ea6537ef618fa2214451d2fd936c87bd80dc394cb1a27e1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42236499. Agents can read the archived copy with the MCP tool read_document.